LINCOLN PHARMACEUTICALS
Back to Cashflow Statement
|
LINCOLN PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-6.40 Cr | ₹-5.18 Cr | ₹-4.50 Cr | ₹-2.56 Cr | ₹-5.75 Cr |
What is the latest Cash Flow from Financing Activities ratio of LINCOLN PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-6.40 Cr |
| Mar2024 | ₹-5.18 Cr |
| Mar2023 | ₹-4.50 Cr |
| Mar2022 | ₹-2.56 Cr |
| Mar2021 | ₹-5.75 Cr |
How is Cash Flow from Financing Activities of LINCOLN PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-6.40 Cr | Negative | |
| Mar2024 | ₹-5.18 Cr | Negative | |
| Mar2023 | ₹-4.50 Cr | Negative | |
| Mar2022 | ₹-2.56 Cr | Negative | |
| Mar2021 | ₹-5.75 Cr | - | |
Compare Cash Flow from Financing Activities of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹993.2 Cr | 4.8% | -0.8% | -39.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹414,929.0 Cr | 0.7% | -4.2% | -8.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,644.0 Cr | 0% | -1% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹131,481.0 Cr | 2.4% | 4.5% | 14.5% | Stock Analytics | |
| CIPLA | ₹122,050.0 Cr | 1.1% | 0.2% | -1.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,784.0 Cr | -1% | -2% | -9.7% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | 4.8% |
-0.8% |
-39.1% |
| SENSEX | 0.9% |
0.7% |
9.6% |
You may also like the below Video Courses